These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 484765)

  • 41. A psychometric evaluation of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease.
    Wang W; Chair SY; Thompson DR; Twinn SF
    J Clin Nurs; 2009 Sep; 18(17):2436-43. PubMed ID: 19694877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
    Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The failing of the MRFIT (multiple risk factor intervention trial)].
    Meijler FL
    Ned Tijdschr Geneeskd; 1982 Dec; 126(52):2390-1. PubMed ID: 7155218
    [No Abstract]   [Full Text] [Related]  

  • 44. [Psychological and physical well-being of cardiological outpatients with chest pain].
    Zimmermann K; Einsle F; Dannemann S; Pollack K; Köllner V; Nitschke-Bertaud M
    Psychother Psychosom Med Psychol; 2010; 60(9-10):368-78. PubMed ID: 20094968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An integrated secondary prevention group programme reduces depression in cardiac patients.
    Turner A; Murphy BM; Higgins RO; Elliott PC; Le Grande MR; Goble AJ; Worcester MU
    Eur J Prev Cardiol; 2014 Feb; 21(2):153-62. PubMed ID: 23147275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease.
    Shekelle RB; Hulley SB; Neaton JD; Billings JH; Borhani NO; Gerace TA; Jacobs DR; Lasser NL; Mittlemark MB; Stamler J
    Am J Epidemiol; 1985 Oct; 122(4):559-70. PubMed ID: 4025299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Ischemic Heart Disease Life Stress Monitoring Program: 18-month mortality results.
    Frasure-Smith N; Prince RH
    Can J Public Health; 1986; 77 Suppl 1():46-50. PubMed ID: 3527398
    [No Abstract]   [Full Text] [Related]  

  • 48. Single case experiments in psychopharmacological trials.
    Wolfrum C; Klieser E; Lehmann E
    Neuropsychobiology; 1984; 12(2-3):152-7. PubMed ID: 6527757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Forms control and error detection procedures used at the Coordinating Center of the Multiple Risk Factor Intervention Trial (MRFIT).
    DuChene AG; Hultgren DH; Neaton JD; Grambsch PV; Broste SK; Aus BM; Rasmussen WL
    Control Clin Trials; 1986 Sep; 7(3 Suppl):34S-45S. PubMed ID: 3802845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Background and organization of quality control in the Multiple Risk Factor Intervention Trial.
    Lasser NL; Lamb S; Dischinger P; Kirkpatrick K
    Control Clin Trials; 1986 Sep; 7(3 Suppl):1S-16S. PubMed ID: 3802835
    [No Abstract]   [Full Text] [Related]  

  • 51. Quality control of screening procedures in the Multiple Risk Factor Intervention Trial.
    Harrison HH; Morgan J
    Control Clin Trials; 1986 Sep; 7(3 Suppl):91S-108S. PubMed ID: 3802848
    [No Abstract]   [Full Text] [Related]  

  • 52. Risk factor screening and intervention: a psychological/behavioral cost or a benefit?
    Benfari RC; Eaker E; McIntyre K; Paul O
    Control Clin Trials; 1981 May; 2(1):3-14. PubMed ID: 7261637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of patterns of smoking behavior change among smokers in the Multiple Risk Factor Intervention Trial (MRFIT).
    Ockene JK; Hymowitz N; Sexton M; Broste SK
    Prev Med; 1982 Nov; 11(6):621-38. PubMed ID: 6761682
    [No Abstract]   [Full Text] [Related]  

  • 54. Measurement of anxiety for patients with cardiac disease: a critical review and analysis.
    De Jong MJ; Hall LA
    J Cardiovasc Nurs; 2006; 21(5):412-9. PubMed ID: 16966920
    [No Abstract]   [Full Text] [Related]  

  • 55. Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.
    J Chronic Dis; 1977 May; 30(5):261-75. PubMed ID: 863996
    [No Abstract]   [Full Text] [Related]  

  • 56. The multiple risk factor intervention trial after 4 years: a summing-up.
    Benfari RC; Sherwin R
    Prev Med; 1981 Jul; 10(4):544-6. PubMed ID: 7027242
    [No Abstract]   [Full Text] [Related]  

  • 57. Reporting clinical trial results.
    Avins AL
    Ann Intern Med; 1993 Jul; 119(1):93-4. PubMed ID: 8498776
    [No Abstract]   [Full Text] [Related]  

  • 58. The psychological effects of differential treatment of a high risk sample in a randomized clinical trial.
    Benfari RC; McIntyre K; Eaker E; Blumberg S; Paul O
    Am J Public Health; 1979 Oct; 69(10):996-1000. PubMed ID: 484765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
    Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
    Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.